 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Select Publications
Allred DC. Problems and solutions in the evaluation of hormone receptors in breast cancer. J Clin Oncol. 2008 May 20;26(15):2433-5. No abstract available
Badve SS et al. Estrogen- and progesterone-receptor status in ECOG 2197: Comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory. J Clin Oncol 2008;26(15):2473-81. Abstract
Ellis MJ et al. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics. J Natl Cancer Inst 008;100(19):1380-8. Abstract
Ellis MJ et al. Outcome prediction for clinical stage II and III ER+ breast cancer based on treatment response, pathological stage, tumor grade, Ki67 proliferation index, and estrogen receptor status after neoadjuvant endocrine therapy. San Antonio Breast Cancer Symposium 2007;Abstract 62.
Kim C et al. A comparison of estrogen receptor (ER) measurement by three methods in node negative, estrogen receptor (ER) positive breast cancer: Ligand binding (LB), immunohistochemistry (IHC), and quantitative RT-PC. San Antonio Breast Cancer Symposium 2006;Abstract 3116.
 |
 |
TOPICS
Challenges in HER2 Testing and Interpretation
- Select publications
Assessment of Estrogen Receptor Status
- Select publications
Evolving Role of Genomic Assays in Breast Cancer
- Select publications
Tissue Biomarkers in the Management of Breast Cancer:
A CME Audio Series and Activity
 |
 |
 |
 |
 |
